Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly ...

Avifavir® is the first product approved in Russia for treatment of coronavirus and the world-first registered product ...

Chromis, a joint venture of the Russian Direct Investment Fund (RDIF) and ChemRar Group, was rated by Rospatent among ...

The high efficacy of Avifavir®, the first registered drug for the treatment of COVID-19, in clinical practice was ...

Indonesia registers Russian drug with proven clinical efficacy against coronavirus Avifavir was the first ...

Chromis (Russia), a joint venture of the ChemRar Group and the Russian Direct Investment Fund (RDIF), and its partner ...